Category Archives: Business and Investments

Latest From Business and Investments

FierceBiotech Names 2014 Fierce 15

FierceBiotech

FierceBiotech released their much-anticipated 2014 Fierce 15 list today, their annual list of private biotech upstarts to watch. We’ll be hearing from three of them at next month’s BIO Investor Forum, October 7-8 in San Francisco: Adaptimmune and Sutro Biopharma will be making company presentations, and Editas Medicine CEO Katrine Bosley will participate as a panelist in one of our therapeutic workshops, Gene Therapy Ascending? Today’s Advancements Over Past Hurdles. Here’s the scoop on each, Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Virtual Resources: BIO BizLink Meets the C&EN Online Trade Show

BIO_BizLink_logo

For those who may not have heard, BIO recently launched a new initiative: BIO BizLink. Powered by OnDeckBiotech, BIO BizLink is a valuable resource for connecting biotech and pharma with an unparalleled community of service providers – including pre-clinical and clinical Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) and regulatory consultants. On BIO BizLink, vendors maintain a no-cost company profile, including an overview of services, reviews provided by past clients, introductions to key personnel Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

CFO Magazine: On the IPO On-Ramp

lab_tech

CFO Magazine highlighted the impact of the Jumpstart Our Business Startups (JOBS) Act on smaller companies aiming to obtain access to capital and the benefits of the JOBS Act by highlighting case studies from companies that went public using it. “Nearly everyone agrees that the JOBS Act has significantly affected the way IPOs are done,” writes Edward Teach. Teach talked to five companies to discuss their experiences, and not surprisingly, ‘all had strong opinions about Read More >

Business and Investments, Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Eyes Have It According to Recent VC Funding Patterns

BIO Investor Forum

A recent Wall Street Journal analysis of venture capital investment trends since 1999 reveals which human body parts are experiencing the biggest rise in funding. The report was based on data from thousands of financings of startups from 1999 through the first half of 2014, provided by VentureSource, a database owned by Dow Jones & Company. And while many would assume the funding was largely pumped in to cardiovascular disease, they would be wrong. “The Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Biotech Analyst Optimism: Price Targets Post-IPO

Stock Ticker

In a recent blog post, Bruce Booth of Life Sci VC, writes about the relationship between a forecasted price target of a biotech stock and its current share price. If biotech stocks hit their current targets, it could be a good year, Booth writes: “I’ll close with a thought experiment as an optimist: if, in line with historic data, 45% of the current IPO class hits their price targets at some point over the next Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,